Last reviewed · How we verify
NCT04248673: DBS
Düsseldorf Bread Study
NA trial testing carbohydrate reduced bread in Body Weight in 80 participants. Completed in 21 October 2021.
21 October 2021
Quick facts
| Lead sponsor | West German Center of Diabetes and Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 1 August 2020 |
| Primary completion | 21 October 2021 |
| Estimated completion | 21 October 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- carbohydrate reduced bread
- carbohydrate rich bread
Conditions studied
- Body Weight — all drugs for Body Weight →
Sponsor
West German Center of Diabetes and Health
Who can join
Adults 18 to 69, any sex, with Body Weight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The hypothesis is to be tested that eating carbohydrate-reduced bread over three months leads to a significant weight difference compared to conventional, carbohydrate-rich bread.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of a Low-Insulin-Stimulating Bread on Weight Development-A Real Life Randomised Controlled Trial.
Kempf K, Röhling M, Kolb H, Martin S. · · 2023 · cited 4× · PMID 36904300 · DOI 10.3390/nu15051301
Verify or expand the search:
- PubMed search for NCT04248673
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Body Weight
Currently open trials in the same condition.
- NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
- NCT06169137 — Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation · NA · recruiting
- NCT06387901 — Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition. · recruiting
- NCT06409962 — A New Technological Intervention to Address Childhood Obesity: · NA · recruiting
- NCT06406192 — Effects of FOR-Care Model on Preventive Medicine · NA · active not recruiting
Other West German Center of Diabetes and Health trials
Trials by the same sponsor.
- NCT06745362 — Weight Reduction With the Low-Insulin-Method - Self Monitoring of Breath Acetone · NA · not yet recruiting
- NCT05933759 — Weight Reduction With the Low-Insulin-Method · NA · completed
- NCT05704491 — AI Screening for Diabetic Retinopathy · recruiting
- NCT04707651 — Formula Diet Treatment for NASH Patients. · NA · active not recruiting
- NCT04593992 — HTEMS Treatment of Diabetic Polyneuropathy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04248673 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by West German Center of Diabetes and Health
- Last refreshed: 28 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248673.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing